General Information of the Compound
| Compound ID |
CP0102434
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
B-HT 920
Show/Hide
|
||||||||||||||||||
| Synonyms |
101626-70-4
4H-Thiazolo[4,5-d]azepin-2-amine,5,6,7,8-tetrahydro-6-(2-propen-1-yl)-
6-Allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo(4,5-d)azepine
6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepin-2-amine
6-prop-2-enyl-4,5,7,8-tetrahydro-[1,3]thiazolo[4,5-d]azepin-2-amine
7AM2J46Z1Y
BHT920
CHEMBL279085
DSSTox_CID_26321
DSSTox_GSID_46321
DSSTox_RID_81537
Domin
NCGC00163160-01
Talipexol
Talipexol [Spanish]
Talipexole
Talipexole (INN)
Talipexole [INN]
Talipexolum
Talipexolum [Latin]
UNII-7AM2J46Z1Y
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C10H15N3S
|
||||||||||||||||||
| Molecular Weight |
209.318
|
||||||||||||||||||
| Canonical SMILES |
Nc1nc2CCN(CC=C)CCc2s1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C10H15N3S/c1-2-5-13-6-3-8-9(4-7-13)14-10(11)12-8/h2H,1,3-7H2,(H2,11,12)
Show/Hide
|
||||||||||||||||||
| InChIKey |
DHSSDEDRBUKTQY-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
101626-70-4
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor
Clinical Information about the Compound